Mysoline (Primidone)

Primidone is metabolised in the liver to phenobarbital, which enhances the activity of the inhibitory neurotransmitter GABA at GABA‑A receptors. This increases chloride influx into neurons, stabilising neuronal membranes and decreasing excessive neuronal firing that leads to seizures.

The dosage of Mysoline is individualised by the prescribing clinician based on factors such as the patient’s age, weight, seizure type, and response to therapy. Only a qualified healthcare professional should determine the appropriate dose and titration schedule.

Safety data for primidone in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risk management with their healthcare provider.

To request Mysoline, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to primidone is phenobarbital, another barbiturate antiepileptic. While both share a similar mechanism, phenobarbital often has a longer half‑life and may be associated with more pronounced sedation. Newer non‑barbiturate agents such as levetiracetam or lamotrigine may offer different side‑effect profiles, but choice depends on individual patient factors and physician judgement.

Mysoline should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and sources of heat. Do not store in bathrooms or near kitchen appliances. Ensure the container is tightly closed when not in use.

Mysoline is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal upset. Tablets (or the appropriate oral form) should be swallowed whole unless the prescriber advises otherwise.

Serious adverse events include severe skin reactions such as Stevens‑Johnson syndrome, blood disorders like agranulocytosis or aplastic anemia, suicidal thoughts or major depression, and significant liver dysfunction. Patients should seek immediate medical attention if they notice rash, unexplained bruising, mood changes, or signs of jaundice.

Mysoline is contraindicated in individuals with known hypersensitivity to primidone, phenobarbital, or any barbiturate component. Caution is also advised for patients with severe hepatic impairment, marked bone‑marrow suppression, or those taking interacting CNS depressants without close supervision.